Worldwide R&D organization is interested in establishing research collaborations with Asian researchers and biotechnology companies working in the field of Neuroscience. Pfizer wishes to establish and progress early stage research collaborations to develop therapeutics, expand the understanding of disease biology and identify biomarkers that impact neurodegenerative and neurological diseases including:
Key Success Criteria
Neurological and psychiatric disorders are a leading cause of disability. To meet these patient needs, Pfizer is taking a bold leadership approach that spans symptomatic to disease-modifying therapies. As a result, Pfizer is investigating new ways to attack Alzheimer’s Disease, Parkinson's Disease, Schizophrenia and other debilitating conditions of the nervous system. Pfizer's neuroscientists are eager to work with world-class partners and collaborators who share our mission to improve the lives of patients suffering from neurological and psychiatric disorders.
Possible Approaches of Interest
Pfizer is specifically interested in supporting projects focused upon:
Areas of No Interest
Pfizer is NOT seeking proposals related to:
Preferred Collaboration Type
Pfizer seeks to establish truly collaborative relationships that bring a high level of interaction between our R&D groups and appropriate partner organizations.
For appropriate opportunities, Pfizer may provide access to many of their key drug discovery and development resources.
Pfizer is particularly interested in partnering opportunities with universities, research institutes or biotechnology companies that reside in China, Hong Kong, Japan, Korean, Taiwan, Singapore or India. Proposals will be assessed upon how well they address the specific partnering needs detailed above, the likelihood of meeting key milestones within a two year period, and upon the track record of the Principle Investigators as demonstrated by a publication record and success in attracting competitive funding.
How to Respond:
We are looking for a completed Response Template, which may contain a concise abstract/executive summary. The proposal should briefly describe the technical approach and provide information on technology performance, background and description of the responding team and their related experience. To Respond, please use the red Respond Now button located to the right. Please note that only non-confidential information can be accepted.
By submitting a response you represent that the response does not contain and will not be deemed to contain any confidential information of any kind whatsoever. All Personal Information disclosed to Pfizer within a response will be utilized in accord with principles and polices as described at http://www.pfizer.com/general/privacy. By submitting a response, you also acknowledge and confirm that you have consulted with your Technology Transfer Office, Business Development Office or any other required group and that you have their approval to submit the response. By submitting a response, you acknowledge that the Need's sponsoring organization, in its sole discretion, may select or reject a response or any portion thereof.
Your NineSights community profile should contain all required information in order to provide us with appropriate contact information for your responses. For questions about NineSights privacy and security, please feel free to post in our forums.